Severe Hemophilia A Completed Phase 3 Trials for Antihemophilic factor, human recombinant (DB00025)

Also known as: Severe Haemophilia A / Hemophilia A, Severe

IndicationStatusPhase
DBCOND0034640 (Severe Hemophilia A)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01181128Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia ATreatment